I bought some Wuxi Pharma (NYSE:WX) shares today, last year I traded it shortly after its IPO in Aug/Sept.
Recent developments
Q4 and full year 2007 results (MSN Money): total net revenues increased 93.3% to $135.2 million (compared to 2006);
Chemsitry CRO of the year by Pfizer;
Q1 2008 results to be released on May 27;
Wuxi postponed secondary offering today; here is F1 prospectus for secondary offering (I have not found its 2007 annual report).
Background (in Chinese)
中国CRO的现状及所面临的挑战